The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(Aminobenzamidino)succinyl analogue ID: ALA1160511
PubChem CID: 10472801
Max Phase: Preclinical
Molecular Formula: C17H22N4O4
Molecular Weight: 346.39
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: C=C[C@H](CC(=O)O)NC(=O)CCC(=O)N(C)c1ccc(C(=N)N)cc1
Standard InChI: InChI=1S/C17H22N4O4/c1-3-12(10-16(24)25)20-14(22)8-9-15(23)21(2)13-6-4-11(5-7-13)17(18)19/h3-7,12H,1,8-10H2,2H3,(H3,18,19)(H,20,22)(H,24,25)/t12-/m1/s1
Standard InChI Key: HVGVVJWPNBZAHP-GFCCVEGCSA-N
Molfile:
RDKit 2D
25 25 0 0 0 0 0 0 0 0999 V2000
-0.8333 -3.2000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.5792 -1.9000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.7250 -3.7917 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.0250 -1.6875 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.3417 0.2083 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8042 0.5833 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.0625 -1.3542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.5625 -2.0625 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.3625 -2.8167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.9667 -0.7667 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.4375 -0.3917 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.5750 -2.5000 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.0417 -1.5250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.7167 1.1708 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.5917 -1.4917 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.0042 -0.6042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0042 -1.8500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.6542 -2.6500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.4583 -2.2292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.1917 -3.0250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.3958 -2.9917 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.0667 -1.1667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.6000 -1.7292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.3625 0.3708 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
0.9292 -1.0917 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 4 1 0
3 1 2 0
4 8 1 0
11 5 1 1
6 5 1 0
7 23 1 0
8 18 1 0
9 1 1 0
10 7 1 0
11 10 1 0
12 2 2 0
13 2 1 0
14 6 2 0
15 7 2 0
16 11 1 0
17 19 1 0
18 20 2 0
19 9 2 0
20 9 1 0
21 1 1 0
22 16 2 0
23 13 1 0
24 6 1 0
25 4 1 0
17 8 2 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 346.39Molecular Weight (Monoisotopic): 346.1641AlogP: 0.86#Rotatable Bonds: 9Polar Surface Area: 136.58Molecular Species: ZWITTERIONHBA: 4HBD: 4#RO5 Violations: ┄HBA (Lipinski): 8HBD (Lipinski): 5#RO5 Violations (Lipinski): ┄CX Acidic pKa: 4.04CX Basic pKa: 11.49CX LogP: -1.90CX LogD: -1.90Aromatic Rings: 1Heavy Atoms: 25QED Weighted: 0.30Np Likeness Score: -0.39
References 1. Zablocki JA, Rico JG, Garland RB, Rogers TE, Williams K, Schretzman LA, Rao SA, Bovy PR, Tjoeng FS, Lindmark RJ.. (1995) Potent in vitro and in vivo inhibitors of platelet aggregation based upon the Arg-Gly-Asp sequence of fibrinogen. (Aminobenzamidino)succinyl (ABAS) series of orally active fibrinogen receptor antagonists., 38 (13): [PMID:7608903 ] [10.1021/jm00013a014 ]